Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reuben S Harris

Showing results (231-240 of 267) with videos related to

Pageof 27
Sort By:
SLAS Discovery : Advancing Life Sciences R & D|August 22, 2024
SARS-CoV-2 M<sup>pro</sup> inhibitor identification using a cellular gain-of-signal assay for high-throughput screeningRenee Delgado, Jyoti Vishwakarma, Seyed Arad Moghadasi, et al.
Nature|February 8, 2013
APOBEC3B is an enzymatic source of mutation in breast cancerMichael B Burns, Lela Lackey, Michael A Carpenter, et al.
Cell Reports. Medicine|October 5, 2023
Human APOBEC3B promotes tumor development in vivo including signature mutations and metastasesCameron Durfee, Nuri Alpay Temiz, Rena Levin-Klein, et al.
Plos Pathogens|September 11, 2020
A role for gorilla APOBEC3G in shaping lentivirus evolution including transmission to humansYusuke Nakano, Keisuke Yamamoto, Mahoko Takahashi Ueda, et al.
ACS Chemical Biology|December 21, 2011
First-in-class small molecule inhibitors of the single-strand DNA cytosine deaminase APOBEC3GMing Li, Shivender M D Shandilya, Michael A Carpenter, et al.
Cell Chemical Biology|January 8, 2025
Targeting N-Myc in neuroblastoma with selective Aurora kinase A degradersJian Tang, Ramkumar Moorthy, Laura E Hirsch, et al.
Science Advances|October 13, 2016
The DNA cytosine deaminase APOBEC3B promotes tamoxifen resistance in ER-positive breast cancerEmily K Law, Anieta M Sieuwerts, Kelly LaPara, et al.
Genome Biology|November 24, 2023
Acute expression of human APOBEC3B in mice results in RNA editing and lethalityAlicia Alonso de la Vega, Nuri Alpay Temiz, Rafail Tasakis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 27, 2016
APOBEC3G Expression Correlates with T-Cell Infiltration and Improved Clinical Outcomes in High-grade Serous Ovarian CarcinomaBrandon Leonard, Gabriel J Starrett, Matthew J Maurer, et al.
Nature|December 23, 2011
Vif hijacks CBF-β to degrade APOBEC3G and promote HIV-1 infectionStefanie Jäger, Dong Young Kim, Judd F Hultquist, et al.
Pageof 27

Showing results (231-240 of 267) with videos related to

Sort By:
Pageof 27
SLAS Discovery : Advancing Life Sciences R & D|August 22, 2024
SARS-CoV-2 M<sup>pro</sup> inhibitor identification using a cellular gain-of-signal assay for high-throughput screeningRenee Delgado, Jyoti Vishwakarma, Seyed Arad Moghadasi, et al.
Nature|February 8, 2013
APOBEC3B is an enzymatic source of mutation in breast cancerMichael B Burns, Lela Lackey, Michael A Carpenter, et al.
Cell Reports. Medicine|October 5, 2023
Human APOBEC3B promotes tumor development in vivo including signature mutations and metastasesCameron Durfee, Nuri Alpay Temiz, Rena Levin-Klein, et al.
Plos Pathogens|September 11, 2020
A role for gorilla APOBEC3G in shaping lentivirus evolution including transmission to humansYusuke Nakano, Keisuke Yamamoto, Mahoko Takahashi Ueda, et al.
ACS Chemical Biology|December 21, 2011
First-in-class small molecule inhibitors of the single-strand DNA cytosine deaminase APOBEC3GMing Li, Shivender M D Shandilya, Michael A Carpenter, et al.
Cell Chemical Biology|January 8, 2025
Targeting N-Myc in neuroblastoma with selective Aurora kinase A degradersJian Tang, Ramkumar Moorthy, Laura E Hirsch, et al.
Science Advances|October 13, 2016
The DNA cytosine deaminase APOBEC3B promotes tamoxifen resistance in ER-positive breast cancerEmily K Law, Anieta M Sieuwerts, Kelly LaPara, et al.
Genome Biology|November 24, 2023
Acute expression of human APOBEC3B in mice results in RNA editing and lethalityAlicia Alonso de la Vega, Nuri Alpay Temiz, Rafail Tasakis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 27, 2016
APOBEC3G Expression Correlates with T-Cell Infiltration and Improved Clinical Outcomes in High-grade Serous Ovarian CarcinomaBrandon Leonard, Gabriel J Starrett, Matthew J Maurer, et al.
Nature|December 23, 2011
Vif hijacks CBF-β to degrade APOBEC3G and promote HIV-1 infectionStefanie Jäger, Dong Young Kim, Judd F Hultquist, et al.
Pageof 27